<International Circulation>: What is the next biggest challenges in this field?

  《国际循环》：在这一领域，下一个最大的挑战是什么？

    Dr. Eeckhout: In the field of revascularization I think that for interventional cardiologists the main issue is the bio-absorbable technology. The fully bio-absorbable stents， which will have limited release in Europe， will be a great breakthrough. I also see that the structural heart disease field as seeing great improvements. I would insist that TAVI， percutaneous treatment of aortic stenosis is an important progress. There are a lot of techniques， such as mitral valve replacement， seems to remain difficult but I think TAVI and progress in percutaneous revascularization devices are things that we will see in the next five to ten years.

    Eeckhout博士：在血运重建领域，我认为，对介入心脏病医生，主要问题是生物可吸收技术。将在欧洲限量发行的完全生物可吸收支架将会是一个很大的突破。我还看到，结构性心脏病领域有很大的进步。我坚持认为TAVI即主动脉瓣狭窄的经皮治疗是一个重大的进展。有很多技术，如二尖瓣置换术，似乎仍然是困难的，但我认为TAVI和经皮血运重建装置的进展是我们在未来五到十年将会看到的事情。